10 | CMXC Reverse Split/CUSIP Change, 11/5/2024: 1:15 | Steel Reserve | 11/04/2024 5:33:29 PM |
9 | $CMXC News Article - Cell MedX Corp.'s eBalance | whytestocks | 09/01/2020 11:45:52 AM |
8 | $CMXC News Article - Cell MedX Corp. Receives | whytestocks | 06/09/2020 1:40:41 PM |
7 | 3 Penny Stocks Making Big Moves This Week; 1 Over | jonny_red32 | 10/24/2019 12:55:52 PM |
6 | CMXC 24% v737K c1.49 f48M H | znewcar1 | 09/16/2019 5:25:01 PM |
5 | $CMXC News Article - Cell MedX Corp. Provides | whytestocks | 09/12/2019 9:15:42 AM |
4 | $CMXC News Article - Cell Medx Corp (OTCMKTS: | whytestocks | 09/09/2019 12:20:45 PM |
3 | I missed yesterday's trade now I have to buy | kiddme | 06/06/2015 4:43:03 PM |
2 | I've got to be in. GO $CMXC. | kiddme | 06/05/2015 2:45:20 PM |
1 | If CMXC is mining in Phillipines then CMXC will | kiddme | 06/03/2015 9:52:31 PM |
Recent Articles
- New Study Links Nightmares to Early Death and Aging Process
- Impact of Nightmares on Lifespan and Biological Aging Revealed
- Enhancing Heart Health: Oral Semaglutide for Diabetes Patients
- Molecular Partners Advances MP0726 with Orano Med Collaboration
- Mim8 Treatment for Haemophilia A: Promising Phase 3 Findings
- Mim8 Brings New Hope for Hemophilia A Patients: Study Insights
- Once-Weekly Insulin Efsitora Shows Promising Outcomes for Diabetes
- Innovative Inhaled Insulin Offers New Hope for Young Diabetics
- Lilly's Efsitora Alfa Offers Innovative Diabetes Treatment Solution
- Innovative Research Sheds Light on Uterine Cancer Treatment Paths
- Investigation of Luminar Technologies: What Investors Should Know
- Investigation Launched into Travere Therapeutics' Practices
- Meta Platforms Faces Investigation: Implications for Investors
- Investigation Launched into ADTRAN Holdings, Inc. (ADTN)
- Class Action Filed Against Red Cat Holdings, Inc. Over Securities
- Investigation on NeuroPace, Inc.: Protecting Investor Interests
- Investigation Launched into Groupon, Inc. - Discover the Details
- Understanding the Class Action Lawsuit Against Broadmark Realty Capital
- PTC Therapeutics Faces Scrutiny Amid Growing Investor Concerns
- Starbucks Faces Lawsuit Over Alleged Labor Code Violations
- Unleashing Daring Challenges: Explore Cajole's Unique Ventures
- Oklahoma City Mayor David Holt Leads New Era for Cities
- Opportunities for Investors in Rocket Pharmaceuticals Class Action
- FinThrive Unveils Agentic AI Technology for Revenue Cycle Success
- Monster Energy Athletes Shine at X Games Osaka, Making History
- Reckitt Benckiser Group Faces Class Action Lawsuit from Investors
- Investigation of Investor Claims Against Sanofi - SNY Alert
- Investigation Issued for NWTN Inc. Investors: Key Insights
- Apple Inc. Faces Class Action Over Siri Features Misleading Claims
- Class Action Lawsuit Against Organon Inc: Important Updates
- Metallus Inc. Faces Investigation: What Investors Should Know
- Legal Action Initiated Against MicroStrategy over Securities Fraud
- Gilead Sciences Under Investigation: What Investors Need to Know
- Abacus Global Management Faces Investigation Amidst Concerns
- Unfolding Legal Concerns Surrounding Rocket Pharmaceuticals Today
- Bitfarms Ltd. Faces Class Action Lawsuit Amid Financial Concerns
- Civitas Resources, Inc. Faces Class Action Lawsuit Over Securities
- Class Action Filed Against Avis Budget Group by Pomerantz LLP
- Vestis Corporation Class Action Lawsuit: Key Details to Know
- Legal Inquiry into Quipt Home Medical Corp. Sparks Investor Action
- Investors Urged to Explore Potential Claims Against Caleres
- Digimarc Corporation Faces Class Action Lawsuit Over Losses
- Fortrea Holdings Faces Class Action Lawsuit Amidst Concerns
- Legal Action Against PepGen Inc. Highlights Investor Concerns
- Investigation of Possible Securities Fraud at 3D Systems Corporation
- Understanding Proficient Auto Logistics, Inc. and Recent Developments
- Understanding Take-Two Interactive's Recent Legal Challenges
- Investor Insights on Dyne Therapeutics: Understanding Risks
- Investors Explore Potential Misconduct by Schrödinger, Inc.
- Flowco Holdings Inc. Faces Legal Scrutiny Amid IPO Discrepancies